KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Inventory (2018 - 2025)

Historic Inventory for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $9.9 million.

  • Adaptive Biotechnologies' Inventory fell 1691.34% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year decrease of 1691.34%. This contributed to the annual value of $8.4 million for FY2024, which is 4158.36% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Inventory stood at $9.9 million, which was down 1691.34% from $8.4 million recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Inventory peaked at $21.0 million during Q1 2022, and registered a low of $8.4 million during Q2 2025.
  • Moreover, its 5-year median value for Inventory was $17.3 million (2022), whereas its average is $15.4 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Inventory surged by 7665.15% in 2021 and then tumbled by 4158.36% in 2024.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Inventory stood at $19.3 million in 2021, then decreased by 24.97% to $14.5 million in 2022, then fell by 0.03% to $14.4 million in 2023, then crashed by 41.58% to $8.4 million in 2024, then increased by 17.69% to $9.9 million in 2025.
  • Its Inventory stands at $9.9 million for Q3 2025, versus $8.4 million for Q2 2025 and $8.7 million for Q1 2025.